Children with bone cancer in their arms or legs survival rate improved

Key points
- Ross Wilkins and Stephen Withrow are doctors working together in the fight against bone cancer.
- Wilkins is one of the world's best-respected orthopedic surgeons at The Denver Clinic for Extremities at Risk at Presbyterian/St.
- Withrow practices in the world's largest veterinary cancer center at Colorado State University.
- Historically, children with bone cancer in their arms or legs faced amputation and, 95% of the time, death.
Ross Wilkins and Stephen Withrow are doctors working together in the fight against bone cancer. Their goals are the same. Their patients are not.
Dr. Wilkins is one of the world's best-respected orthopedic surgeons at The Denver Clinic for Extremities at Risk at Presbyterian/St. Luke's Medical Center. His patients are people.
Dr. Withrow practices in the world's largest veterinary cancer center at Colorado State University. His patients are dogs.
Historically, children with bone cancer in their arms or legs faced amputation and, 95% of the time, death. Now, thanks to the unlikely collaboration of human and veterinary medicine, the odds have been reversed to a cure rate of over 90%, usually with the limb intact.
The team at The Denver Clinic established advanced diagnostic criteria and pre-operative, intra-arterial chemotherapy protocols that have dramatically increased success rates for these children. Wilkins, a world leader in reversing the odds for patients with osteosarcoma, will tell you that his veterinarian friend Stephen Withrow deserves a lot of the credit.
Wilkins tapped into Withrow's knowledge for good reason - bone cancer occurs in large dogs 10 times more frequently than in humans. Working together, the two doctors developed revolutionary "limb-sparing" surgical procedures now used worldwide on animals and humans; they pioneered surgical, chemotherapy, and radiation protocols that are shared daily with physicians around the world; and they developed unique biodegradable chemotherapy "sponges" to combat osteosarcoma at the site of the tumor and aid post-operative chemotherapy and radiation.
http://www.pslmc.com/
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
News2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma
A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can predict which patients with Hodgkin's lymphoma are most likely to develop radiation-induced…
25 July 2011
NewsDrug shows promise in prostate cancer spread to bone
A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows. The drug Cabozantinib is designed to target mainly two important pathways…
8 June 2011
NewsBone drug zoledronic acid may help prevent spread of early lung cancer
A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian…







